Red flags / Going concern

CTSOCytosorbents CorporationElevatedForm 10-Qfiled Nov 19, 7:00 AM ET

CytoSorbents says cash and debt terms raise substantial doubt about its going concern status

The 10-Q states that as of September 30, 2026, CytoSorbents held about $5.7 million in cash and restricted cash, of which $4.2 million was unrestricted and available to fund operations. Management concludes that these balances, together with historical and expected cash use, the Strategic Workforce and Cost Reduction Plan and the Amended Loan and Security Agreement, raise substantial doubt about its ability to continue as a going concern within twelve months. Such a disclosure matters for investors because it signals the company may need to raise additional capital or restructure its debt, with dilution or financing terms as possible outcomes.

“These cash and restricted cash balances considered with the Company's historical and expected future cash used in operations, notwithstanding the Company's Strategic Workforce and Cost Reduction Plan (see Note 11, "Restructuring") and the impact of the Amended Loan and Security Agreement (see Note 6, "Long-Term Debt") raises substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that the accompanying condensed consolidated financial statements are issued.”

What the stock did

From the last close before the filing was public. Market cap now: $13M.

1 day
-7.8%
SPY -2.0%
5 days
Not yet
 
20 days
Not yet
 

10-K or 10-Q says there is substantial doubt the company can keep operating. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.

Other flags on CTSO

FiledStockFlagWhat the filing saysMkt cap5 days20 days
Nov 20, 8:58 AM ETCTSO
Cytosorbents Corporation
Dilution
ElevatedForm 424B5
CytoSorbents sells 855,637 shares and pre-funded warrants in $3.5 million registered direct offering$13M--
Nov 17, 6:28 AM ETCTSO
Cytosorbents Corporation
Late filing
SevereForm NT 10-Q
CytoSorbents delays 10-Q filing over review of foreign currency exchange gains and losses$13M--